Harrow Closes Acquisition of Tyrvaya from Viatris
Key Takeaways
Harrow completed its acquisition of worldwide rights to Tyrvaya, excluding Japan, for $30 million upfront…
#London #Britain #UnitedKingdom #UK #GB #England #Headlines #News #Europe #EU #Harrow #Business #Cataract #Cornea #Glaucoma #HarrowHealth #MergersandAcquisitions #ophthalmology #Optometry #Refractive #TYRVAYA®
https://www.europesays.com/gbr/london/35551/